Showing 1 – 20 of 195
Relevance | Newest | Oldest |
  • Labeling Accuracy of Cannabidiol Extracts Sold Online

    Abstract Full Text
    JAMA. 2017; 318(17):1708-1709. doi: 10.1001/jama.2017.11909

    This study compares ingredients listed on the labels of cannabidiol products sold online to actual product constituents determined by laboratory analysis.

  • Selections From News@JAMA and JAMA Forum

    Abstract Full Text
    JAMA. 2013; 309(13):1336-1336. doi: 10.1001/jama.2013.2760
  • Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products

    Abstract Full Text
    free access
    JAMA. 2015; 313(24):2491-2493. doi: 10.1001/jama.2015.6613

    This study analyzed the dose accuracy of labels from edibile medical cannabis products dispensed in 3 US cities.

  • Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders

    Abstract Full Text
    JAMA. 2017; 317(10):1070-1071. doi: 10.1001/jama.2016.19706

    This commentary discusses a national survey study published in JAMA Psychiatry that found cannabis use within the general population is associated with an increased risk for substance use disorders.

  • Substance Use Disorder Among Anesthesiology Residents, 1975-2009

    Abstract Full Text
    free access
    JAMA. 2013; 310(21):2289-2296. doi: 10.1001/jama.2013.281954

    Warner and coauthors conducted a retrospective cohort study of 44 612 physicians in anesthesiology residency programs to describe the incidence and outcomes of substance use disorder among a subset of US physicians.

  • Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer Beware

    Abstract Full Text
    JAMA. 2016; 315(21):2338-2339. doi: 10.1001/jama.2016.5181

    This commentary discusses a cohort study published in JAMA Psychiatry that investigated associations between cannabis use over 20 years and physical health problems in midlife.

  • Association Between Marijuana Exposure and Pulmonary Function Over 20 Years

    Abstract Full Text
    free access has multimedia
    JAMA. 2012; 307(2):173-181. doi: 10.1001/jama.2011.1961
  • Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Substance Dependence: A Randomized Controlled Trial

    Abstract Full Text
    free access
    JAMA. 2012; 308(7):690-699. doi: 10.1001/jama.2012.9071
    To assess the effectiveness of an integrated therapy for posttraumatic stress disorder (PTSD) and substance dependence, Mills and coauthors randomized 103 patients with PTSD and substance dependence to receive integrated therapy plus usual treatment or usual treatment alone. In the related Editorial, Najavits discusses the importance of expanding options for treatment of PTSD.
  • Mortality in a Cohort of Street Youth in Montreal

    Abstract Full Text
    free access
    JAMA. 2004; 292(5):569-574. doi: 10.1001/jama.292.5.569
  • Cognitive Functioning of Long-term Heavy Cannabis Users Seeking Treatment

    Abstract Full Text
    free access
    JAMA. 2002; 287(9):1123-1131. doi: 10.1001/jama.287.9.1123
  • Modulation of the Immune System in Cannabis Users

    Abstract Full Text
    JAMA. 2003; 289(15):1929-1931. doi: 10.1001/jama.289.15.1929-a
  • Effect of a Housing and Case Management Program on Emergency Department Visits and Hospitalizations Among Chronically Ill Homeless Adults: A Randomized Trial

    Abstract Full Text
    free access
    JAMA. 2009; 301(17):1771-1778. doi: 10.1001/jama.2009.561
  • Screening and Brief Intervention for Drug Use in Primary Care: The ASPIRE Randomized Clinical Trial

    Abstract Full Text
    free access has multimedia
    JAMA. 2014; 312(5):502-513. doi: 10.1001/jama.2014.7862

    Saitz and coauthors tested the efficacy of 2 brief interventions among 528 adults with unhealthy drug use identified by screening in primary care. They compared a brief negotiated interview and an intervention based on motivational interviewing with no brief intervention. In an Editorial, Hingson and Compton discuss the importance of exploring drug use with patients in primary care.

  • Cannabis Smoking and Periodontal Disease Among Young Adults

    Abstract Full Text
    free access
    JAMA. 2008; 299(5):525-531. doi: 10.1001/jama.299.5.525
  • Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial

    Abstract Full Text
    free access is active quiz has multimedia
    JAMA. 2015; 313(16):1636-1644. doi: 10.1001/jama.2015.3474

    A randomized trial involving opioid-dependent patients found that buprenorphine treatment with coordinated follow-up for ongoing treatment was more effective than referral with or without brief intervention.

  • Liver Transplantation and Opioid Dependence

    Abstract Full Text
    free access
    JAMA. 2001; 285(8):1056-1058. doi: 10.1001/jama.285.8.1056
  • Cannabinoids for Medical Use: A Systematic Review and Meta-analysis

    Abstract Full Text
    free access
    JAMA. 2015; 313(24):2456-2473. doi: 10.1001/jama.2015.6358

    This meta-analysis summarizes the effectiveness of cannabis and cannabinoids for managing medical and psychotic disorders, including chemotherapy-induced nausea and vomiting, chronic pain, and mood and sleep disorders.

  • Integrating Primary Medical Care With Addiction Treatment: A Randomized Controlled Trial

    Abstract Full Text
    free access
    JAMA. 2001; 286(14):1715-1723. doi: 10.1001/jama.286.14.1715
  • US Spending on Personal Health Care and Public Health, 1996-2013

    Abstract Full Text
    free access has multimedia
    JAMA. 2016; 316(24):2627-2646. doi: 10.1001/jama.2016.16885

    This study used data from National Health Expenditure Accounts to estimate US spending on personal health care and public health, according to condition, age and sex group, and type of care.

  • Integrating Tobacco Cessation Into Mental Health Care for Posttraumatic Stress Disorder: A Randomized Controlled Trial

    Abstract Full Text
    free access
    JAMA. 2010; 304(22):2485-2493. doi: 10.1001/jama.2010.1769